Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis

被引:58
作者
Murphy, Sarah E. [1 ]
Bicanic, Tihana [1 ,2 ]
机构
[1] St Georges Univ London, Inst Infect & Immun, London, England
[2] St Georges Univ Hosp Natl Hlth Serv NHS Fdn Trust, Clin Acad Grp Infect & Immun, London, England
关键词
Candida; invasive candidiasis; candidaemia; antifungal resistance; antifungal drugs; drug therapy; drug resistance; antimicrobial resistance; BROAD-SPECTRUM ANTIFUNGAL; GLUCAN SYNTHASE INHIBITOR; LONG-ACTING ECHINOCANDIN; IN-VITRO ACTIVITY; INFECTIOUS-DISEASES SOCIETY; CELECOXIB DERIVATIVE AR-12; HIGHLY POTENT INHIBITOR; AMPHOTERICIN-B; MURINE MODEL; TREHALOSE-6-PHOSPHATE PHOSPHATASE;
D O I
10.3389/fcimb.2021.759408
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Candida species are the leading cause of invasive fungal infections worldwide and are associated with acute mortality rates of ~50%. Mortality rates are further augmented in the context of host immunosuppression and infection with drug-resistant Candida species. In this review, we outline antifungal drugs already in clinical use for invasive candidiasis and candidaemia, their targets and mechanisms of resistance in clinically relevant Candida species, encompassing not only classical resistance, but also heteroresistance and tolerance. We describe novel antifungal agents and targets in pre-clinical and clinical development, including their spectrum of activity, antifungal target, clinical trial data and potential in treatment of drug-resistant Candida. Lastly, we discuss the use of combination therapy between conventional and repurposed agents as a potential strategy to combat the threat of emerging resistance in Candida.
引用
收藏
页数:22
相关论文
共 235 条
[21]   Combining Colistin and Fluconazole Synergistically Increases Fungal Membrane Permeability and Antifungal Cidality [J].
Bibi, Maayan ;
Murphy, Sarah ;
Benhamou, Raphael, I ;
Rosenberg, Alex ;
Ulman, Adi ;
Bicanic, Tihana ;
Fridman, Micha ;
Berman, Judith .
ACS INFECTIOUS DISEASES, 2021, 7 (02) :377-389
[22]   Colistin interacts synergistically with echinocandins against Candida auris [J].
Bidaud, A. L. ;
Djenontin, E. ;
Botterel, F. ;
Chowdhary, A. ;
Dannaoui, E. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (03)
[23]  
BioPharma M., 2014, MAT8800 DISC PROGR M
[24]   Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species [J].
Borman, Andrew M. ;
Szekely, Adrien ;
Johnson, Elizabeth M. .
MSPHERE, 2016, 1 (04)
[25]   Hyphal orientation of Candida albicans is regulated by a calcium-dependent mechanism [J].
Brand, Alexandra ;
Shanks, Scott ;
Duncan, Vanessa M. S. ;
Yang, Meng ;
Mackenzie, Kevin ;
Gow, Neil A. R. .
CURRENT BIOLOGY, 2007, 17 (04) :347-352
[26]   A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis [J].
Brand, Stephen R. ;
Degenhardt, Thorsten P. ;
Person, Karen ;
Sobel, Jack D. ;
Nyirjesy, Paul ;
Schotzinger, Robert J. ;
Tavakkol, Amir .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (06) :624.e1-624.e9
[27]   VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice [J].
Break, Timothy J. ;
Desai, Jigar V. ;
Healey, Kelley R. ;
Natarajan, Mukil ;
Ferre, Elise M. N. ;
Henderson, Christina ;
Zelazny, Adrian ;
Siebenlist, Ulrich ;
Yates, Christopher M. ;
Cohen, Oren J. ;
Schotzinger, Robert J. ;
Perlin, David S. ;
Garvey, Edward P. ;
Lionakis, Michail S. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (08) :2089-2094
[28]   VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans [J].
Break, Timothy J. ;
Desai, Jigar V. ;
Natarajan, Mukil ;
Ferre, Elise M. N. ;
Henderson, Christina ;
Zelazny, Adrian M. ;
Siebenlist, Ulrich ;
Hoekstra, William J. ;
Schotzinger, Robert J. ;
Garvey, Edward P. ;
Lionakis, Michail S. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (01) :151-155
[29]   Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitis [J].
Brouwer, Annemarie E. ;
van Kan, Hendrikus J. M. ;
Johnson, Elizabeth ;
Rajanuwong, Adul ;
Teparrukkul, Prapit ;
Wuthiekanun, Vannaporn ;
Chierakul, Wirongrong ;
Day, Nick ;
Harrison, Thomas S. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (03) :1038-1042
[30]   Antifungal drug resistance evoked via RNAi-dependent epimutations [J].
Calo, Silvia ;
Shertz-Wall, Cecelia ;
Lee, Soo Chan ;
Bastidas, Robert J. ;
Nicolas, Francisco E. ;
Granek, Joshua A. ;
Mieczkowski, Piotr ;
Torres-Martinez, Santiago ;
Ruiz-Vazquez, Rosa M. ;
Cardenas, Maria E. ;
Heitman, Joseph .
NATURE, 2014, 513 (7519) :555-+